Hormone Replacement Therapy Market Introduction and Overview
According to SPER Market Research, the Global Hormone Replacement Therapy Market is estimated to reach USD 63.47 billion by 2033 with a CAGR of 5.32%.
The report includes an in-depth analysis of the Global Hormone Replacement Therapy Market, including market size and trends, product mix, Applications, and supplier analysis. Hormone replacement therapy (HRT) is the use of hormones to replace natural hormones when the body's production is insufficient. Thyroid and human growth hormone patients, for example, might be offered hormone replacement treatment. Furthermore, HRT was often administered to menopausal women to relieve symptoms such as hot flushes, night sweats, sleep disturbances, psychological & Genito-urinary disorders (urinary frequency and vaginal dryness), and to prevent osteoporosis. While HRT can provide significant relief and improve quality of life for people suffering from hormone imbalances, it is not without dangers and should be carefully reviewed and managed by a healthcare practitioner.
- 2022: Ascendis Pharma A/S has acquired European Commission approval to sell its medication SKYTROFA for the treatment of growth hormone abnormalities in children and adolescents.
- 2021: Theramex has announced the clearance of Bijuva / Bijuve throughout Europe and the United Kingdom. Bijuva is a body-identical hormone therapy (HRT) treatment for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least 12 months since last menstruation that contains oestradiol and progesterone in a single daily oral capsule.
- 2020: The US Food and Drug Administration approved Myovant Sciences' Orgovyx (relugolix), an orally administered treatment that works by preventing the pituitary gland from producing luteinizing hormone and follicle-stimulating hormone, resulting in a decrease in the amount of testosterone produced by the testicles. This helps to treat adult patients with advanced prostate cancer.
Market Opportunities and Challenges
The rise in the frequency of menopausal problem and increased mindfulness about post-menopausal enterprises among women are two main reasons driving the growth of the global hormone replacement treatment request. Likewise, new hormone replacement treatment launches are likely to significantly contribute to the growth of the hormone relief replacement request. The arrival of bioidentical hormone replacement treatment and the use of telemedicine for hormone replacement remedy are projected to produce an economic occasion for the worldwide hormone replacement remedy request to expand in the near future. Rising mindfulness about Medicinals, as well as studies being accepted by the government and marketable companies for development in detecting the dangerous factors for the body, are anticipated to fuel request expansion.
Still, multitudinous specialized and functional obstacles, similar as Hormone replacement remedy is associated with a high threat of problems. Post-therapy complications include sleep apnea, acne or other skin responses, bone growth, an increased threat of blood clots, and numerous others. As a result, request expansion is hampered. The high cost of these drugs will really limit request growth.
Market Competitive Landscape
The global hormone replacement treatment industry is highly competitive, and major competitors have used a variety of techniques to gain the most market share. Collaboration, product launch, partnership, and acquisition are among the strategies. To meet the increased need for hormone replacement therapy products, key corporations are launching strategic initiatives. The major players in the market include: Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Merck KGA, Mylan N.V., Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Merck KGA, Mylan N.V., Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.
|
COVID-19 Impact on Global Hormone Replacement Therapy Market
Throughout the protuberance period, Covid 19 had a significant impact on the hormone replacement therapy assiduity. The transition of healthcare structure to manage COVID- 19 has redounded in drug launch cancellations and clinical trial detainments. Cases with COVID- 19 who had abnormal hormone attention during hospitalisation were set up to have an advanced threat of complaint inflexibility and inflammation in both men and women. According to exploration, COVID- 19 enhances the need for hormone treatment and will accelerate request expansion. Whereas many other studies have indicated that the remedy be halted during COVID- 19, potentially affecting request growth.
Key Target Audience:
- Andropause Men
- Menopausal Women
- Patients with Hormonal Disorder
Our in-depth analysis of the Hormone Replacement Therapy Market includes the following segments:
|
By Therapy Type:
|
Estrogen hormone replacement therapy Filtration
Human growth hormone replacement therapy Pipes
Progestogen hormone replacement therapy
Testosterone hormone replacement therapy
Thyroid hormone replacement therapy
|
|
By Route of Administration:
|
Oral
Parenteral
|
|
By Indication:
|
Growth hormone deficiency
Hypothyroidism
Male hypogonadism
Menopause
|
|
By Distribution Channel:
|
Hospital Pharmacies
Online Pharmacy
Retail Pharmacy
|
|
By End Use:
|
Homecare
Hospitals
Speciality Clinics
|
Key Topics Covered in the Report:
- Global Hormone Replacement Therapy Market Size (FY’2023-FY’2033)
- Overview of Global Hormone Replacement Therapy Market
- Segmentation of Global Hormone Replacement Therapy Market By Therapy Type (Estrogen hormone replacement therapy Filtration, Human growth hormone replacement therapy Pipes, Progestogen hormone replacement therapy, Testosterone hormone replacement therapy, Thyroid hormone replacement therapy)
- Segmentation of Global Hormone Replacement Therapy Market By Route of Administration (Oral, Parenteral, Others)
- Segmentation of Global Hormone Replacement Therapy Market By Indication (Growth hormone deficiency, Hypothyroidism, Male hypogonadism, Menopause, Others)
- Segmentation of Global Hormone Replacement Therapy Market By Distribution Channel (Hospital Pharmacies, Online Pharmacy, Retail Pharmacy)
- Segmentation of Global Hormone Replacement Therapy Market By End Use (Hospitals, Homecare, Speciality Clinics, Others)
- Statistical Snap of Global Hormone Replacement Therapy Market
- Expansion Analysis of Global Hormone Replacement Therapy Market
- Problems and Obstacles in Global Hormone Replacement Therapy Market
- Competitive Landscape in the Global Hormone Replacement Therapy Market
- Impact of COVID-19 and Demonetization on Global Hormone Replacement Therapy Market
- Details on Current Investment in Global Hormone Replacement Therapy Market
- Competitive Analysis of Global Hormone Replacement Therapy Market
- Prominent Players in the Global Hormone Replacement Therapy Market
- SWOT Analysis of Global Hormone Replacement Therapy Market
- Global Hormone Replacement Therapy Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Hormone Replacement Therapy Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Hormone Replacement Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hormone Replacement Therapy Market
7. Global Hormone Replacement Therapy Market, By Therapy Type (USD Million)
7.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Therapy Type, 2023-2033
7.2. Estrogen hormone replacement therapy Filtration
7.3. Human growth hormone replacement therapy Pipes
7.4. Progestogen hormone replacement therapy
7.5. Testosterone hormone replacement therapy
7.6. Thyroid hormone replacement therapy
8. Global Hormone Replacement Therapy Market, By Route of Administration (USD Million)
8.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Route of Administration, 2023-2033
8.2. Oral
8.3. Parenteral
8.4. Others
9. Global Hormone Replacement Therapy Market, By Indication (USD Million)
9.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Indication, 2023-2033
9.2. Growth hormone deficiency
9.3. Hypothyroidism
9.4. Male hypogonadism
9.5. Menopause
9.6. Others
10. Global Hormone Replacement Therapy Market, By Distribution Channel (USD Million)
10.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Distribution Channel, 2023-2033
10.2. Hospital Pharmacies
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Global Hormone Replacement Therapy Market, By End Use (USD Million)
11.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By End Use, 2023-2033
11.2. Homecare
11.3. Hospitals
11.4. Speciality Clinics
11.5. Others
12. Global Hormone Replacement Therapy Market Forecast, 2019-2033 (USD Million)
12.1. Global Hormone Replacement Therapy Market Size and Market Share
13. Global Hormone Replacement Therapy Market, By Therapy Type, 2019-2033 (USD Million)
13.1. Global Hormone Replacement Therapy Market Size and Market Share By Therapy Type (2019-2026)
13.2. Global Hormone Replacement Therapy Market Size and Market Share By Therapy Type (2027-2033)
14. Global Hormone Replacement Therapy Market, By Route of Administration, 2019-2033 (USD Million)
14.1. Global Hormone Replacement Therapy Market Size and Market Share By Route of Administration (2019-2026)
14.2. Global Hormone Replacement Therapy Market Size and Market Share By Route of Administration (2027-2033)
15. Global Hormone Replacement Therapy Market, By Indication, 2019-2033 (USD Million)
15.1. Global Hormone Replacement Therapy Market Size and Market Share By Indication, (2019-2026)
15.2. Global Hormone Replacement Therapy Market Size and Market Share By Indication, (2027-2033)
16. Global Hormone Replacement Therapy Market, By Distribution Channel, 2019-2033 (USD Million)
16.1. Global Hormone Replacement Therapy Market Size and Market Share By Distribution Channel, (2019-2026)
16.2. Global Hormone Replacement Therapy Market Size and Market Share By Distribution Channel, (2027-2033)
17. Global Hormone Replacement Therapy Market, By End Use, 2019-2033 (USD Million)
17.1. Global Hormone Replacement Therapy Market Size and Market Share By End Use (2019-2026)
17.2. Global Hormone Replacement Therapy Market Size and Market Share By End Use (2027-2033)
18. Global Hormone Replacement Therapy Market, By Region, 2019-2033 (USD Million)
18.1. Global Hormone Replacement Therapy Market Size and Market Share By Region (2019-2026)
18.2. Global Hormone Replacement Therapy Market Size and Market Share By Region (2027-2033)
18.3. Asia-Pacific
18.3.1. Australia
18.3.2. China
18.3.3. India
18.3.4. Japan
18.3.5. South Korea
18.3.6. Rest of Asia-Pacific
18.4. Europe
18.4.1. France
18.4.2. Germany
18.4.3. Italy
18.4.4. Spain
18.4.5. United Kingdom
18.4.6. Rest of Europe
18.5. Middle East and Africa
18.5.1. Kingdom of Saudi Arabia
18.5.2. United Arab Emirates
18.5.3. Rest of Middle East & Africa
18.6. North America
18.6.1. Canada
18.6.2. Mexico
18.6.3. United States
18.7. Latin America
18.7.1. Argentina
18.7.2. Brazil
18.7.3. Rest of Latin America
19. Company Profile
19.1. Abbott Laboratories
19.1.1. Company details
19.1.2. Financial outlook
19.1.3. Product summary
19.1.4. Recent developments
19.2. Bayer AG
19.2.1. Company details
19.2.2. Financial outlook
19.2.3. Product summary
19.2.4. Recent developments
19.3. Eli Lilly and Company
19.3.1. Company details
19.3.2. Financial outlook
19.3.3. Product summary
19.3.4. Recent developments
19.4. F. Hoffmann-La Roche Ltd.
19.4.1. Company details
19.4.2. Financial outlook
19.4.3. Product summary
19.4.4. Recent developments
19.5. Hisamitsu Pharmaceutical Co. Inc.
19.5.1. Company details
19.5.2. Financial outlook
19.5.3. Product summary
19.5.4. Recent developments
19.6. Merck KGA
19.6.1. Company details
19.6.2. Financial outlook
19.6.3. Product summary
19.6.4. Recent developments
19.7. Mylan N.V.
19.7.1. Company details
19.7.2. Financial outlook
19.7.3. Product summary
19.7.4. Recent developments
19.8. Novartis International AG
19.8.1. Company details
19.8.2. Financial outlook
19.8.3. Product summary
19.8.4. Recent developments
19.9. Noven Pharmaceuticals, Inc.
19.9.1. Company details
19.9.2. Financial outlook
19.9.3. Product summary
19.9.4. Recent developments
19.10. Novo Nordisk A/S
19.10.1. Company details
19.10.2. Financial outlook
19.10.3. Product summary
19.10.4. Recent developments
19.11. Pfizer Inc
19.11.1. Company details
19.11.2. Financial outlook
19.11.3. Product summary
19.12. Others
20. List of Abbreviations
21. Reference Links
22. Conclusion
23. Research Scope